|
⚲
|
| Keyboard |
| Hazeltine Mark
✚
|
|
|---|---|
| CIK # | 0001852986 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001852986] | |
| 4 | [0001852986] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hazeltine Mark | |
| Exagen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Exagen Inc XGN
Common Stock
|
2023-03-02 | Sell | 3,667 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2023-02-27 | Grant | 100,000 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2023-02-08 | Sell | 5,821 | $2.69 | 15,658 |
|
Exagen Inc XGN
Common Stock
|
2022-03-01 | Tax withheld | 3,241 | $7.12 | 23,076 |
|
Exagen Inc XGN
Common Stock
|
2022-02-04 | Grant | 63,500 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2021-05-17 | Option exercise | 1,934 | $0.26 | 503 |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2021-05-17 | Option exercise | 1,934 | $0.26 | 503 |